Showing 51-60 out of 123
Page 6 of 13« First«...45678...»Last »
Remaining burden of hereditary angioedema (HAE) attacks despite modern long-term prophylaxisBetschel S, van Kooten S, Heckmann M, Danese S, Caballero T
EAACI 2023
Short-Term Prophylaxis with Sebetralstat, an Investigational Oral On-Demand Treatment for Hereditary Angioedema, in KONFIDENT-SBernstein JA, Riedl MA, Lumry WR, Audhya PK, Smith MD, Yea CM
EAACI 2023
Results From a Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial Evaluating Sebetralstat Pharmacokinetics, Pharmacodynamics, and Safety/Tolerability in Healthy Japanese, Chinese, and White AdultsHide M, Iverson M, Jhee S, Hansen E, Duckworth EJ, Hampton SL, Yoon E, Honda D
EAACI 2023
Patients delay treating hereditary angioedema (HAE) attacks with currently available, injectable, on-demand therapies: associated with on-demand treatment of hereditary angioedema (HAE) attacksValerieva A, van Kooten S, Heckmann M, Danese S, Goga L, Longhurst H
EAACI 2023
Sebetralstat Effectiveness in the Treatment of Hereditary Angioedema Attacks Rated Mild or Moderate at Baseline in the Phase 2 TrialLonghurst HJ, Smith MD, Yea CM, Audhya PK
EAC 2023
Reporting of Administration Site Reactions with Parenteral Drugs for the On-Demand Treatment of Hereditary Angioedema Attacks –Analysis of the FAERS Database 2009 to 2022Tachdjian R, Savic S, Fridman M, Frade J, Audhya PK
EAC 2023
Preferences of People with Hereditary Angioedema for On-Demand Treatment: A US-Based Qualitative StudyBukstein D, Desai V, Goga L, Brown M, Settipane RA
EAC 2023
Characterizing Attack-Related Health Utility in Hereditary AngioedemaCraig T, Cribbs KA, Czado S
ISPOR 2023
A Systematic Review of Healthcare Resource Utilization and Direct Medical Costs in Hereditary AngioedemaCraig T, Cribbs KA, Czado S
ISPOR 2023
A Systematic Review of Socioeconomic Burden in Hereditary AngioedemaCraig T, Cribbs KA, Czado S
ISPOR 2023
